Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David DeMets

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|October 13, 2010
A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humansCharles H Hennekens, Wendy R Schneider, Alex Pokov, et al.
Contemporary Clinical Trials|July 6, 2010
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitusCharles H Hennekens, Patricia R Hebert, Wendy R Schneider, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2013
Aspirin increases nitric oxide formation in chronic stable coronary diseaseScott Hetzel, David DeMets, Ricky Schneider, et al.
Therapeutic Innovation & Regulatory Science|April 17, 2023
The Data Monitoring Committee: A Collective or a Collection?Janet Wittes, Thomas Fleming, David DeMets, et al.
JACC. Heart Failure|May 16, 2021
The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic CardiomyopathyBethany Doran, Chaoqun Mei, Paul D Varosy, et al.
JAMA|February 6, 2026
Menopausal Hormone Labels Should Rely on Evidence, Not OpinionJanet Wittes, Eugene Braunwald, Margaret A Chesney, et al.
Circulation. Heart Failure|November 12, 2010
Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE)Michel Komajda, Peter E Carson, Scott Hetzel, et al.
Trials|October 18, 2022
Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19Peter A G Sandercock, Janet Darbyshire, David DeMets, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|February 6, 2010
The Wisconsin Network for Health Research (WiNHR): a statewide, collaborative, multi-disciplinary, research groupHoward Bailey, William Agger, Dennis Baumgardner, et al.
Journal of Cardiac Failure|May 10, 2005
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)Mihai Gheorghiade, Cesare Orlandi, John C Burnett, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology and Therapeutics|October 13, 2010
A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humansCharles H Hennekens, Wendy R Schneider, Alex Pokov, et al.
Contemporary Clinical Trials|July 6, 2010
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitusCharles H Hennekens, Patricia R Hebert, Wendy R Schneider, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2013
Aspirin increases nitric oxide formation in chronic stable coronary diseaseScott Hetzel, David DeMets, Ricky Schneider, et al.
Therapeutic Innovation & Regulatory Science|April 17, 2023
The Data Monitoring Committee: A Collective or a Collection?Janet Wittes, Thomas Fleming, David DeMets, et al.
JACC. Heart Failure|May 16, 2021
The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic CardiomyopathyBethany Doran, Chaoqun Mei, Paul D Varosy, et al.
JAMA|February 6, 2026
Menopausal Hormone Labels Should Rely on Evidence, Not OpinionJanet Wittes, Eugene Braunwald, Margaret A Chesney, et al.
Circulation. Heart Failure|November 12, 2010
Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE)Michel Komajda, Peter E Carson, Scott Hetzel, et al.
Trials|October 18, 2022
Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19Peter A G Sandercock, Janet Darbyshire, David DeMets, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|February 6, 2010
The Wisconsin Network for Health Research (WiNHR): a statewide, collaborative, multi-disciplinary, research groupHoward Bailey, William Agger, Dennis Baumgardner, et al.
Journal of Cardiac Failure|May 10, 2005
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)Mihai Gheorghiade, Cesare Orlandi, John C Burnett, et al.
Pageof 6